Welcome to our dedicated page for Personalis SEC filings (Ticker: PSNL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Personalis's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Personalis's regulatory disclosures and financial reporting.
Personalis, Inc. director and Chief Executive Officer Christopher M. Hall reported paired option exercises and share sales in company stock. He exercised options to acquire 100,000 shares of common stock at an exercise price of $1.61 per share and sold 100,000 shares of common stock in open-market transactions at a weighted average price of $15.08 per share, with sale prices ranging from $15.00 to $15.24. The filing notes that these transactions were effected pursuant to a pre-arranged Rule 10b5-1 trading plan. One transaction entry shows Hall holding 235,986 shares directly after the reported sale, while another shows 335,986 shares directly after the related option exercise.
Morgan Stanley Smith Barney LLC filed a notice under Rule 144 proposing the sale of 100,000 shares of Common Stock on 07/09/2026 following the exercise of stock options for cash. The filing lists an aggregate value of $1,411,000.00.
The filing also discloses recent Rule 10b5-1 sales by Christopher Hall: 100,000 shares on 06/26/2026 (proceeds $1,314,580), 80,091 shares on 05/29/2026 (proceeds $882,843.09), and 19,909 shares on 05/28/2026 (proceeds $219,319.42).
Personalis, Inc. executive Aaron Tachibana, the company’s CFO and COO, reported an exercise-and-sell transaction in company stock. He exercised stock options covering 4,982 shares of common stock at an exercise price of $5.32 per share, then sold 4,982 shares of common stock in an open-market sale at $14.00 per share. According to the disclosure, these trades were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 7, 2025, which means the timing was set in advance. After the transactions, Tachibana directly held 198,833 shares of Personalis common stock.
PSNL filed a Rule 144 notice reporting the proposed sale of 4,982 shares of Common Stock via exercise of stock options, scheduled 06/29/2026. The filing also lists recent 10b5-1 sales by Aaron Tachibana totaling 129,050 shares across three trades in May–June 2026 with aggregate proceeds shown as $1,605,140.20.
Personalis, Inc. CFO and COO Aaron Tachibana reported an option exercise and stock sale. On June 26, 2026, he exercised stock options to acquire a total of 51,251 shares of common stock at strike prices of $5.32 and $9.16 per share.
On the same date, he sold 51,251 shares of common stock in open-market transactions at a weighted average price of $13.18 per share, with individual prices ranging from $13.00 to $13.30. After these transactions, he directly held 198,833 shares of Personalis common stock. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan, indicating they were pre-scheduled rather than discretionary.
Personalis, Inc. Chief Executive Officer Christopher M. Hall reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire 100,000 shares of common stock at $1.61 per share, then sold 100,000 shares of common stock in an open-market transaction at a weighted average price of $13.15 per share, with sale prices ranging from $13.00 to $13.36.
Following these transactions, Hall directly holds 235,986 shares of Personalis common stock and 200,000 stock options. The filing states that both the sales and the option exercise were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 17, 2025, indicating the activity was scheduled in advance.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Form 144 notice related to Common shares tied to an Exercise of Stock Options on 06/26/2026. The notice lists 51,251 shares to be sold for cash. It also discloses prior 10b5-1 sales by Aaron L. Tachibana of 40,000 shares on 06/04/2026 ($480,584) and 38,799 shares on 05/29/2026 ($449,273.02).
Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of 100,000 shares of Common Stock of PSNL on 06/26/2026 in connection with an exercise of stock options for cash. The filing also lists 10b5-1 sales by Christopher Hall of 80,091 shares for $882,843.09 on 05/29/2026 and 19,909 shares for $219,319.42 on 05/28/2026.
EASTHAM KARIN reported acquisition or exercise transactions in this Form 4 filing.
Personalis, Inc. director Karin Eastham reported an amended insider transaction showing a grant of 6,250 shares of Common Stock, in the form of restricted stock units (RSUs), with no cash paid per share. After this award, she is shown as beneficially owning 19,756 shares. The RSUs vest 100% on the earlier of one year from grant or the day before the next annual stockholder meeting, subject to continued service, and vest immediately before any qualifying Change in Control. The amendment corrects the number of shares previously reported as beneficially owned.